ArticleResearch square2024

Evaluation of Exploratory Fluid Biomarker Results from a Phase 1 Senolytic Trial in Mild Alzheimer's Disease.

Valentina R Garbarino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.